1. First Description of a blaVIM-2-Carrying Citrobacter freundii Isolate in Spain
- Author
-
Carmen Torres, Yolanda Sáenz, Sonia Algarate, Cristina Seral, Francisco Javier Castillo, Beatriz Rojo-Bezares, Nerea Porres-Osante, Soledad Salvo, and Vanesa Estepa
- Subjects
Pharmacology ,medicine.medical_specialty ,biology ,Public health ,biochemical phenomena, metabolism, and nutrition ,bacterial infections and mycoses ,biology.organism_classification ,Enterobacteriaceae ,beta-Lactamases ,Citrobacter freundii ,Microbiology ,Infectious Diseases ,Spain ,polycyclic compounds ,medicine ,bacteria ,Pharmacology (medical) ,Letters to the Editor ,Bacteria ,Carbapenem resistance - Abstract
The increasing prevalence of carbapenem-resistant Enterobacteriaceae and nonfermenting Gram-negative bacteria is a growing public health threat. The carbapenemase acquisition is one of the most clinically important and reported carbapenem resistance mechanisms, highlighting metallo-beta-lactamases (
- Published
- 2014